DE69931791D1 - Pharmazeutische zusammensetzung die ein inhibierendes effekt auf die überproduktion und akkumulation der extrazellulären matrix hat - Google Patents

Pharmazeutische zusammensetzung die ein inhibierendes effekt auf die überproduktion und akkumulation der extrazellulären matrix hat

Info

Publication number
DE69931791D1
DE69931791D1 DE69931791T DE69931791T DE69931791D1 DE 69931791 D1 DE69931791 D1 DE 69931791D1 DE 69931791 T DE69931791 T DE 69931791T DE 69931791 T DE69931791 T DE 69931791T DE 69931791 D1 DE69931791 D1 DE 69931791D1
Authority
DE
Germany
Prior art keywords
inhibitant
overproduction
accumulation
effect
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69931791T
Other languages
English (en)
Other versions
DE69931791T2 (de
Inventor
Satoshi Sasaki
Yoshihiko Sumi
Reginald Colin Hughes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of DE69931791D1 publication Critical patent/DE69931791D1/de
Application granted granted Critical
Publication of DE69931791T2 publication Critical patent/DE69931791T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69931791T 1998-08-06 1999-08-05 Pharmazeutische zusammensetzung die ein inhibierendes effekt auf die überproduktion und akkumulation der extrazellulären matrix hat Expired - Lifetime DE69931791T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23349998 1998-08-06
JP23349998 1998-08-06
PCT/JP1999/004238 WO2000007624A2 (en) 1998-08-06 1999-08-05 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix

Publications (2)

Publication Number Publication Date
DE69931791D1 true DE69931791D1 (de) 2006-07-20
DE69931791T2 DE69931791T2 (de) 2007-05-24

Family

ID=16955990

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69931791T Expired - Lifetime DE69931791T2 (de) 1998-08-06 1999-08-05 Pharmazeutische zusammensetzung die ein inhibierendes effekt auf die überproduktion und akkumulation der extrazellulären matrix hat

Country Status (6)

Country Link
EP (1) EP1104307B1 (de)
JP (1) JP2002522398A (de)
AU (1) AU5065399A (de)
DE (1) DE69931791T2 (de)
HK (1) HK1038308A1 (de)
WO (1) WO2000007624A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100172D0 (sv) * 2001-01-22 2001-01-22 Ulf Nilsson New inhibitors against galectins
JP2002322082A (ja) * 2001-04-26 2002-11-08 Purotejiin:Kk 腎炎の予防・治療剤
JP2006522163A (ja) * 2003-04-07 2006-09-28 グリコジェネシス， インク． ガレクチンアンタゴニストの組成物と使用
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
CA2582428A1 (en) 2004-03-26 2005-10-13 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
JP2005314252A (ja) * 2004-04-27 2005-11-10 Okayama Univ 糖尿病性腎症の予防・治療剤
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
SE0401300D0 (sv) * 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
AR099707A1 (es) * 2014-03-10 2016-08-10 La Jolla Pharma Co Composiciones y métodos para tratar trastornos renales
CN113711036A (zh) 2019-01-30 2021-11-26 真和制药有限公司 抗gal3抗体及其用途
WO2021195020A1 (en) * 2020-03-23 2021-09-30 G3 Pharmaceuticals, Inc. Methods and compositions for preventing and treating fibrosis resulting from a coronavirus infection

Also Published As

Publication number Publication date
DE69931791T2 (de) 2007-05-24
EP1104307B1 (de) 2006-06-07
HK1038308A1 (en) 2002-03-15
WO2000007624A2 (en) 2000-02-17
JP2002522398A (ja) 2002-07-23
AU5065399A (en) 2000-02-28
WO2000007624A3 (en) 2000-06-22
EP1104307A2 (de) 2001-06-06

Similar Documents

Publication Publication Date Title
DE69814086D1 (de) Arzneimittel für die kombination piperidinoalkanol-dekongestivum
ATE290837T1 (de) Medikamentenversorgung der sub-tenon
ATE250432T1 (de) Pharmazeutische zusammensetzung auf wasserbasis
ITMI951021A0 (it) Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
FI954402A (fi) Uusi farmaseuttinen tuote
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
DE69822209D1 (de) ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON
ID26420A (id) Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi
DE69712839D1 (de) Tcas computer und anzeige
PT1095025E (pt) Benzimidazoles sua producao e sua utilizacao como medicamentos
DE69904677T2 (de) Zusammensetzung, die ein Trübungs- oder Perlglanzmittel und mindestens einen Fettalkohol enthält
DE69300913D1 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
DE69931791D1 (de) Pharmazeutische zusammensetzung die ein inhibierendes effekt auf die überproduktion und akkumulation der extrazellulären matrix hat
IT8921786A0 (it) Composizioni farmaceutiche ad attivita' sulla microcircolazione cutanea.
PT1049706E (pt) Novos penta-sacaridos os respectivos metodos de producao e as composicoes farmaceuticas que os contem
EE9900440A (et) Farmatseutilised kompositsioonid
NO20011103D0 (no) Lokal avlevering av legemidler til hjertet
DE69830259D1 (de) Gewebeschutzmittel und der Gebrauch desselben
PT1235809E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocinas substituidas e sua utilizacao como medicamentos
NO994436D0 (no) Farmasöytiske sammensetninger
BR1100782A (pt) Fenilimidazolidinas substituìdas, sua aplicação como medicamentos e as composições farmacêuticas que as contêm
FI103158B (fi) Näyttöelementti
ITRM920045A0 (it) Composizioni farmaceutiche ad attivita' anti-aging.
ES1027140Y (es) Triturador de pastillas medicinales y similares.
ITMI921950A1 (it) Composizioni farmaceutiche ad attivita' epato-trofica ed anti-aging

Legal Events

Date Code Title Description
8364 No opposition during term of opposition